What are the recommended first‑line and second‑line treatment options for rosacea?

Rosacea Treatment Recommendations

For inflammatory papules/pustules (mild to moderate rosacea), start with topical azelaic acid, ivermectin, or metronidazole as first-line therapy, escalating to oral doxycycline 40 mg for moderate-to-severe disease or treatment failures. 1

First-Line Treatment by Phenotype

Treatment must be directed by the specific clinical features present, as rosacea manifests with distinct phenotypes requiring different therapeutic approaches. 1

Inflammatory Papules/Pustules

Mild disease:

• Topical azelaic acid 1
• Topical ivermectin 1
• Topical metronidazole 1

Moderate disease:

• Topical azelaic acid 1
• Topical ivermectin 1
• Oral doxycycline (40 mg has demonstrated superiority to placebo and non-inferiority to 100 mg) 1

Severe disease:

• Topical ivermectin 1
• Oral doxycycline 1
• Oral isotretinoin (for therapy-resistant cases) 1, 2

Persistent Erythema

First-line options:

• Topical brimonidine (alpha-adrenergic agonist for vasoconstriction) 1
• Intense pulsed light (IPL) 1
• Topical metronidazole 1
• Oral doxycycline 1

Transient Erythema (Flushing)

Note: Evidence quality is limited to case reports and clinical experience for flushing treatments. 1

First-line options:

• Topical alpha-adrenergics 1
• Oral beta blockers 1
• Pulsed-dye laser (PDL) 1
• Oral doxycycline 1

Telangiectasia

First-line options:

• Electrodessication 1
• Intense pulsed light (IPL) 1
• Lasers 1

Phymatous Changes

Treatment depends on whether the phyma is clinically inflamed ("active") versus clinically non-inflamed ("fibrotic" or "burnt out"). 1

Clinically inflamed phyma:

• Oral doxycycline 1

Clinically non-inflamed phyma:

• Physical modalities (dermabrasion, surgical resurfacing, electrosurgery) 1, 3

Second-Line Treatment Strategy

If first-line treatment fails, either switch to an alternative first-line option from the same phenotype category OR add an additional first-line agent. 1

Combination Therapy Approach

• Multiple cutaneous features can be treated simultaneously with more than one agent. 1
• Moderate and severe presentations require combination treatments, which may include general skincare, physical modalities, and pharmaceutical agents. 1
• For mild presentations, opinion is divided between monotherapy versus combination therapy. 1

Essential Baseline Management (All Patients)

General skincare measures are foundational for all rosacea patients regardless of phenotype: 1

• SPF 30+ sunscreen daily 1
• Moisturizers 1
• Gentle cleansers 1
• Trigger avoidance 1, 4

Ocular Rosacea Management

Very mild ocular rosacea not bothering the patient does not require referral. 1

For greater severity not controlled with lid hygiene, refer to ophthalmology. 1

Dermatologists can prescribe artificial tear substitutes for mild ocular burning/stinging prior to referral. 1

Topical options for ocular involvement include ciclosporin eye drops, azithromycin, ivermectin, or metronidazole. 2

Maintenance Therapy Principles

• Use the minimum treatment necessary to maintain control. 1
• Treatments should be used for sufficient duration before switching (duration is treatment-specific). 1
• Maintenance approach depends on treatment modality and patient preference for ongoing therapy. 1

Common Pitfalls

• Not all products or indications are licensed in every country—always consult local labeling. 1
• Delays in diagnosis occur in skin of color due to difficulty visualizing erythema and telangiectasia. 4
• Topical medications can be irritant in patients with sensitive skin—in such cases, systemic therapy may be the preferred first choice. 5
• Rosacea significantly affects emotional health and quality of life—address psychosocial impact during management. 4